<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50255">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01886729</url>
  </required_header>
  <id_info>
    <org_study_id>EC 11/18/146</org_study_id>
    <nct_id>NCT01886729</nct_id>
  </id_info>
  <brief_title>Effect of Time Shift of Transcranial Direct Current Stimulation (tDCS) for Treatment of Acute Tinnitus</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment for patients with acute tinnitus consists of Methylprednisolone and hyperbaric
      oxygen therapy. For this study  transcranial direct current stimulation (tDCS) was added to
      the protocol. The purpose is to determine the effect of the time shift of tDCS. Two
      conditions will be compared: tDCS simultaneously with the hyperbaric oxygen therapy or tDCS
      3 weeks after the start of the tinnitus.

      An audiological testing will be performed at the day of admission, after 3 weeks, 6 weeks
      and 12 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Improvement of tinnitus</measure>
    <time_frame>12 weeks</time_frame>
    <description>Tinnitus Questionnaire, Visual Analog Scale, Beck Depression Index, Hyperacusis questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hearing</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Audiometry, Otoacoustic emissions, Tympanometry, Speech in noise</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>tDCS simultaneously with hyperbaric oxygen therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS 3 weeks after start tinnitus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>transcranial direct current stimulation (tDCS)</intervention_name>
    <arm_group_label>tDCS simultaneously with hyperbaric oxygen therapy</arm_group_label>
    <arm_group_label>tDCS 3 weeks after start tinnitus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 and 50 years

          -  presence of acute tinnitus or worsening of tinnitus caused by otogenic disease

          -  registration in UZA within 48 hours after start tinnitus

          -  VAS-score ≥ 4

          -  ability to understand and sign informed consent

        Exclusion Criteria:

          -  history of epileptic seizures

          -  severe organic comorbidity

          -  psychiatric disorders or a history of psychiatric disorders with psychotic symptoms

          -  Pace maker

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Sarah Rabau</last_name>
    <phone>003238215235</phone>
    <email>sarah.rabau@uza.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital of Antwerp</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Rabau</last_name>
      <phone>003238215235</phone>
      <email>sarah.rabau@uza.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 25, 2013</lastchanged_date>
  <firstreceived_date>June 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>Ethisch Comité UZ Antwerpen</investigator_full_name>
    <investigator_title>Sarah Rabau</investigator_title>
  </responsible_party>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>time shift</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
